クローン病の腸管狭窄、治療後の残存リスクをMRIで層別化 ー炎症と構造的重症度を組み合わせた新たな評価法を開発ー

ad

2026-10-16 東京科学大学

東京科学大学の研究チームは、クローン病患者に生じる腸管狭窄について、治療開始前のMRI画像から、薬物治療後も狭窄が残存するリスクを予測する評価法を開発した。研究では、MRエンテログラフィー(MRE)画像に基づき、腸壁の肥厚や潰瘍など炎症活動性を評価するA-scoreと、狭窄の長さや狭窄部より上流の腸管拡張など、構造的な重症度を評価するP-scoreを作成した。両スコアを組み合わせた指標は、狭窄の改善と残存を識別する性能としてAUC 0.90を示し、既存のMRE指標を上回った。また、治療後も狭窄が残った群では、その後に腸管手術を受けた割合が29%で、改善群の3%より高かった。本手法は、炎症の強さだけでなく、腸管の構造変化も評価する点が特徴である。今後、多施設での前向き検証が必要だが、治療効果の予測や個別化医療、手術リスクを踏まえた経過観察の改善に役立つことが期待される。

クローン病の腸管狭窄、治療後の残存リスクをMRIで層別化 ー炎症と構造的重症度を組み合わせた新たな評価法を開発ー
図1. 腸管狭窄に対する評価スコアを開発

<関連情報>

ベースライン磁気共鳴腸管造影検査によるクローン病狭窄の持続リスクの層別化 Baseline Magnetic Resonance Enterography Stratifies Persistence Risk of Crohn’s Disease Strictures

Kento Takenaka ∙ Junichi Tsuchiya ∙ Ami Kawamoto ∙ … ∙ Toshimitsu Fujii ∙ Kazuo Ohtsuka ∙ Ryuichi Okamoto
Clinical Gastroenterology and Hepatology  Published:September 15, 2026
DOI:https://doi.org/10.1016/j.cgh.2026.09.007

Abstract

Background & Aims
Crohn’s disease strictures are clinically important, but persistence after advanced therapy remains difficult to assess. We developed and temporally validated a magnetic resonance enterography–based framework integrating activity-related and structural imaging severity to stratify stricture nonimprovement.

Methods
This 2-stage study included patients with Crohn’s disease who initiated advanced therapy and underwent baseline and follow-up magnetic resonance enterography. An activity-related score (A-score) and a persistence-associated structural score (P-score) were derived from a development cohort (2012–2020) and applied to a temporally separated validation cohort (2021–2024). The primary end point was stricture-level nonimprovement on follow-up magnetic resonance enterography; intestinal surgery was also evaluated.

Results
The development cohort included 115 patients with 161 strictures, and the validation cohort included 72 patients with 104 strictures. The A-score comprised bowel wall thickness >6 mm, ulceration, and comb sign; the P-score comprised stricture length >3 cm, prestenotic bowel diameter >3 cm, and a lack of intramural edema. A-score and P-score positivity were each associated with stricture nonimprovement after multivariable adjustment (adjusted odds ratios, 18.68 and 19.75, respectively; P < .01 for both). The summed A + P score showed an area under the curve of 0.90 and a higher discrimination than either score, the segmental magnetic resonance index of activity, or the segmental simplified Magnetic Resonance Index of Activity alone. Improvement rates decreased with increasing A-scores and remained low at higher P-scores. Baseline A/P strata also differed in surgery-free survival (P < .01).

Conclusions
Baseline magnetic resonance enterography integrating activity-related and structural imaging severity stratified stricture persistence and was associated with subsequent surgery. This framework should be interpreted as a baseline imaging severity and risk stratification tool rather than an inflammatory-fibrotic phenotype classifier.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました